Actuate Therapeutics, Inc. Common stock (ACTU) is a publicly traded Healthcare sector company. As of August 14, 2026, ACTU trades at $1.01 with a market cap of $23.21M and a P/E ratio of -0.95. ACTU moved +4.60% today. Year to date, ACTU is -83.83%; over the trailing twelve months it is -88.57%. Its 52-week range spans $0.91 to $11.99. Analyst consensus is strong buy with an average price target of $9.50. Rallies surfaces ACTU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ACTU insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1.01 |
| Market Cap | $23.21M |
| P/E Ratio | -0.95 |
| EPS | $-1.06 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.99 |
| 52-Week Low | $0.91 |
| Volume | 107.95K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-22.23M |
| Gross Margin | 0.00% |
4 analysts cover ACTU: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.50.